Medline ® Abstract for Reference 5
of 'Clinical course and management of monoclonal gammopathy of undetermined significance'
Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence.
Rajkumar SV, Kyle RA, Buadi FK
Mayo Clin Proc. 2010;85(10):945.
Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. email@example.com